Astria Therapeutics, Inc.

NasdaqGM:ATXS Stock Report

Market Cap: US$544.6m

Astria Therapeutics, Inc. Company Information

Astria Therapeutics, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Astria Therapeutics, Inc.
  • Ticker: ATXS
  • Exchange: NasdaqGM
  • Founded: 2008
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$544.590m
  • Shares Outstanding: 56.43m
  • Website: https://www.astriatx.com

Number of Employees


Location

  • Astria Therapeutics, Inc.
  • 75 State Street
  • Suite 1400
  • Boston
  • Massachusetts
  • 02109
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ATXSNasdaqGM (Nasdaq Global Market)YesCommon SharesUSUSDJun 2015

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/25 03:45
End of Day Share Price 2024/11/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.